No association between CALHM1 polymorphism and Alzheimer's disease risk in a Hungarian population

Psychiatric Genetics

Volumn 21, Issue 5, 2011, Pages 249-252

  Fehér, Ágnes ^a   Juhász, Anna ^a   Rimanóczy, Ágnes ^a   Pákáski, Magdolna ^a   Kálmán, János ^a   Janka, Zoltán ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Alzheimer's disease; apolipoprotein E; calcium homeostasis modulator 1; single nucleotide polymorphism

Indexed keywords

APOLIPOPROTEIN E; CALCIUM BINDING PROTEIN; CALCIUM HOMEOSTASIS MODULATOR 1; UNCLASSIFIED DRUG;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR;

EID: 85027955161     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3283457bcc     Document Type: Article

References (13)

1. Beecham GW, Schnetz-Boutaud N, Haines JL, Pericak-Vance MA (2009). CALHM1 polymorphism is not associated with late-onset Alzheimer disease. Ann Hum Genet 73:379-381.
2. Bertram L, Schjeide BM, Hooli B, Mullin K, Hiltunen M, Soininen H, et al. (2008). No association between CALHM1 and Alzheimer's disease risk. Cell 135:993-994.
3. Bezprozvanny I, Mattson MP (2008). Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 31:454-463.
4. Brouwers N, Sleegers K, Van Broeckhoven C (2008). Molecular genetics of Alzheimer's disease: an update. Ann Med 40:562-583.
5. Cedazo-Ḿinguez C, Cowburn RF (2001). Apolipoprotein E: a major piece in the Alzheimer's disease puzzle. J Cell Mol Med 5:254-266.
6. 2+ homeostasis, Ab levels, and Alzheimer's disease risk. Cell 133:1149-1161. (Pubitemid 351863682)
7. Green KN, Demuro A, Akbari Y, Hitt BD, Smith IF, Parker I, et al. (2008). SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. J Cell Biol 181:1107-1116. (Pubitemid 351915486)
8. Kálmán J, Juhász A, Császár A, Kanka A, Maglóczky E, Bencsik K, et al. (1997). Apolipoprotein E allele frequencies in patients with late-onset sporadic Alzheimer's dementia in Hungary. Acta Neurol Scand 95: 56-59. (Pubitemid 27094783)
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944. (Pubitemid 14076461)
10. Minster RL, Demirci FY, DeKosky ST, Kamboh MI (2009). No association between CALHM1 variation and risk of Alzheimer disease. Hum Mutat 30:E566-E569.
11. Sleegers K, Brouwers N, Bettens K, Engelborghs S, van Miegroet H, De Deyn PP, et al. (2009). No association between CALHM1 and risk for Alzheimer dementia in a Belgian population. Hum Mutat 30:E570-E574.
12. Stefani M, Liguri G (2009). Cholesterol in Alzheimer's disease: unresolved questions. Curr Alzheimer Res 6:15-29.
13. Tanzi RE, Bertram L (2008). Alzheimer's disease: the latest suspect. Nature 454:706-708.